 |
市場調査レポート
商品コード
1285918
神経補綴の世界市場 - 市場規模、シェア、成長分析：用途別、技術別、タイプ別、業界予測（2023年～2030年）Global Neuroprosthetics Market Size, Share, Growth Analysis, By Application, By Technique, By Type - Industry Forecast 2023-2030 |
||||||
| 神経補綴の世界市場 - 市場規模、シェア、成長分析：用途別、技術別、タイプ別、業界予測（2023年～2030年） |
|
出版日: 2023年04月22日
発行: SkyQuest
ページ情報: 英文 157 Pages
納期: 3～5営業日
|
- 全表示
- 概要
- 目次
世界の神経補綴の市場規模は、2021年に215億米ドルとなり、予測期間（2023年～2030年）のCAGRは11.8%と見込まれています。同市場は、2022年の240億3,000万米ドルから2030年には541億7,000万米ドルまで拡大すると予測されています。
当レポートは、世界の神経補綴市場について調査し、市場の概要とともに、用途別、技術別、タイプ別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
エグゼクティブサマリー
親市場分析
市場規模
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
主要な市場の洞察
- 技術分析
- 価格分析
- サプライチェーン分析
- バリューチェーン分析
- 市場のエコシステム
- IP分析
- 動向分析
- スタートアップ分析
- 原材料分析
- イノベーションマトリックス
- パイプライン製品分析
- マクロ経済指標
- トップ投資分析
- 主な成功要因
- 競合の程度
市場力学と展望
- 市場力学
- 促進要因
- 機会
- 抑制要因
- 課題
- 規制状況
- ポーター分析
世界の神経補綴市場、用途別
- 市場概要
- 運動ニューロン障害
- 生理的疾患
- 認知障害
世界の神経補綴市場、技術別
- 市場概要
- 脳の刺激
- 脊髄刺激
- 迷走神経刺激
- その他
世界の神経補綴市場、タイプ別
- 市場概要
- 出力用
- 入力用
世界の神経補綴市場、地域別
- 市場概要
- 北米
- 欧州
- アジア太平洋
- ラテンアメリカ
- 中東・アフリカ
競合情勢
- 主要企業プロファイル
- Abbott Laboratories
- Boston Scientific Corporation
- Cochlear Limited
- Cyberonics, Inc.
- Edwards Lifesciences Corporation
- Envoy Medical Corporation
- Medtronic plc
- MicroPort Scientific Corporation
- NDI Medical LLC
- NeuroPace, Inc.
- Nevro Corp.
- Otto Bock HealthCare GmbH
- Retina Implant AG
- Second Sight Medical Products, Inc.
- Sonova Holding AG
- St. Jude Medical, Inc.
- Synapse Biomedical, Inc.
- Terumo Corporation
- Thoratec Corporation
- Zimmer Biomet Holdings, Inc.
Neuroprosthetics Market size was valued at USD 21.5 billion in 2021 and is poised to grow from USD 24.03 billion in 2022 to USD 54.17 billion by 2030, growing at a CAGR of 11.8% in the forecast period (2023-2030).
The global neuroprosthetics market is experiencing steady growth due to advancements in medical technology. Neuroprosthetics are devices designed to restore or improve neural functions, benefiting individuals with disabilities or neurological disorders. The market is driven by increasing research and development activities, rising prevalence of neurological disorders, and growing demand for effective treatment options. Technological innovations and expanding healthcare infrastructure are expected to further propel market growth in the coming years.
Top-down and bottom-up approaches were used to estimate and validate the size of Neuroprosthetics and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Segments covered in this report:
Global neuroprosthetics market is segmented on the basis of application, technique, type, and region. By application, the market is segmented into motor neuron disorders, physiological disorders, and cognitive disorders. By technique, the market is categorized into deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, and others. By type, the market is bifurcated into output neural prosthetics and input neural prosthetics. By region, the market is divided into North America, Europe, Asia Pacific, Latin America, and MEA.
Driver
The global neuroprosthetics market is anticipated to experience significant growth during the forecast period, primarily driven by the high prevalence of neurological disorders and nerve-related injuries. These conditions are expected to be the key factors contributing to the market's expansion. To illustrate, neurological diseases alone have caused over 533,000 fatalities, with approximately 213,000 reported among males and around 320,000 among females. Neuroprosthetics devices offer numerous advantages for treating such diseases, making them an effective solution. Additionally, individuals suffering from hearing impairments can benefit from these devices, including cochlear implants and auditory brainstem implants (ABIs). Consequently, the growing demand for neuroprosthetics worldwide, which aids in the diagnosis and management of various disorders, is expected to drive the market's growth in the forthcoming years.
Restrain
The rising acceptance of alternative treatment approaches such as stem cell therapy presents significant prospects for addressing different neurological conditions. However, this trend is expected to impede the growth of the market in the foreseeable future. Stem cell therapy provides advantageous treatment options for neurological disorders like Parkinson's and Alzheimer's, offering cost-effective alternatives and simplified medication protocols that appeal to patients. As a result, this factor is likely to limit the worldwide expansion of the neuroprosthetics market during the projected period.
Trend
The increasing prevalence of hearing loss and advancements in technology have led to a rise in the popularity of neural prosthetics. These devices, which offer the ability to perceive sound to individuals who are deaf or hard of hearing, are becoming more appealing due to their user-friendly nature and affordable implementation costs. These factors present promising opportunities for the growth of neural prosthetics in the coming years. Additionally, our research indicates that cochlear implantation not only aids in diagnosing hearing loss but also shows potential as a therapeutic tool for rehabilitating tinnitus patients. As a result, the neuroprosthetics market is projected to experience significant expansion in the foreseeable future.
Table of Contents
Executive Summary
- Market Overview
- Wheel of Fortune
- Research Methodology
- Information Procurement
- Secondary & Primary Data Sources
- Market Size Estimation
- Market Assumptions & Limitations
Parent Market Analysis
- Market Overview
- Market Size
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Key Market Insights
- Technology Analysis
- Pricing Analysis
- Supply Chain Analysis
- Value Chain Analysis
- Ecosystem of the Market
- IP Analysis
- Trade Analysis
- Startup Analysis
- Raw Material Analysis
- Innovation Matrix
- Pipeline Product Analysis
- Macroeconomic Indicators
- Top Investment Analysis
- Key Success Factor
- Degree of Competition
- Market Dynamics & Outlook
- Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
- Regulatory Landscape
- Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers
- Skyquest Special Insights on Future Disruptions
- Political Impact
- Economic Impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Global Neuroprosthetics Market by Application
- Market Overview
- Motor Neuron Disorders
- Physiological Disorders
- Cognitive Disorders
- Global Neuroprosthetics Market by Technique
- Market Overview
- Brain Stimulation
- Spinal Cord Stimulation
- Vagus Nerve Stimulation
- others
Global Neuroprosthetics Market by Type
- Market Overview
- Output Neural Prosthetics
- Input Neural Prosthetics
- Global Neuroprosthetics Market Size by Region
- Market Overview
- North America
- USA
- Canada
- Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America
- Brazil
- Rest of Latin America
- Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA
- Competitive Landscape
- Top 5 Player Comparison
- Market Positioning of Key Players, 2021
- Strategies Adopted by Key Market Players
- Top Winning Strategies
- By Development
- By Company
- By Year
- Recent Activities in the Market
- Key Companies Market Share (%), 2021
- Key Company Profiles
- Abbott Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Boston Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cochlear Limited
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cyberonics, Inc. (LivaNova PLC)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Edwards Lifesciences Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Envoy Medical Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Medtronic plc
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- MicroPort Scientific Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NDI Medical LLC
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- NeuroPace, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nevro Corp.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Otto Bock HealthCare GmbH
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Retina Implant AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Second Sight Medical Products, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sonova Holding AG
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- St. Jude Medical, Inc. (Abbott Laboratories)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Synapse Biomedical, Inc. (Zynex, Inc.)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Terumo Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thoratec Corporation (Abbott Laboratories)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Zimmer Biomet Holdings, Inc.
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
